Studies on the effect of oral hypoglycaemic agents on hepatic glycogenolysis.
D000092:Acetohexamide / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D003864:Depression, Chemical; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D005952:Glucose-6-Phosphatase / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D066298:In Vitro Techniques; D008099:Liver / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D008112:Liver Glycogen / Q000378:metabolism*; D008297:Male; D008687:Metformin / Q000494:pharmacology; D010629:Phenformin / Q000494:pharmacology; D006005:Phosphorylases / Q000378:metabolism; D051381:Rats; D013449:Sulfonamides / Q000494:pharmacology; D014044:Tolbutamide / Q000494:pharmacology
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D008112:Liver Glycogen; D013449:Sulfonamides; D008687:Metformin; D014044:Tolbutamide; D010629:Phenformin; D006005:Phosphorylases; D005952:Glucose-6-Phosphatase; D000092:Acetohexamide